2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $3.5B | $2.2B | $3.2B | $3.3B | $3.1B |
Cost of Revenue | $2.5B | $1.9B | $2.1B | $2.2B | $2.1B |
Gross Profit | $1B | $311M | $1.1B | $1.1B | $975M |
Gross Profit % | 29% | 14% | 33% | 33% | 32% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $94M | -$489M | $154M | $163M | $29M |
Dep. & Amort. | $87M | $88M | $78M | $81M | $66M |
Def. Tax | -$2.9M | $34M | -$1M | -$52M | $9.1M |
Stock Comp. | $17M | $24M | $29M | $29M | $29M |
Chg. in WC | -$11M | $48M | -$91M | -$38M | $22M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $87M | $60M | $73M | $59M | $49M |
ST Investments | $25M | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $112M | $60M | $73M | $59M | $49M |
Receivables | $89M | $196M | $200M | $78M | $84M |
Inventory | $633M | $473M | $586M | $606M | $571M |
DBI reported positive comparable sales in Q4 FY24 for the first time in nine quarters, with U.S. Retail comps up 1% and Canada Retail comps up 5%.
Full-year FY24 adjusted EPS was $0.27, at the upper end of the revised guidance range of $0.10 to $0.30, with total company sales down 2% year-over-year.
For FY25, DBI expects low single-digit sales growth, positive comps, and adjusted EPS in the range of $0.30 to $0.50, representing nearly a 50% increase at the midpoint compared to FY24.
The company plans to focus on inventory productivity, assortment revitalization, and omnichannel enhancements, while adding new DSW stores for the first time since 2019 and expanding private label brands to drive margins.
DBI anticipates $45M-$55M in capital expenditures for FY25 and has outlined cost-saving initiatives, including fewer promotions and operational efficiencies, to support gross margin improvement.